A Roche Molecular Systems test for flu and Covid-19 has the potential for false positive results, according to an alert from the U.S. Food and Drug Administration.
- The co.’s cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas Liat System could produce erroneous results due to sporadic leaking of the assay tubes and abnormal PCR cycling in the reaction tubes
To contact the reporter on this story:
To contact the editor responsible for this story:
© 2021 Bloomberg L.P. All rights reserved. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.